Skip to main content

Find Clinical Trials

Home
Conditions
Respiratory Tract Infections

Clinical trial condition

Respiratory Tract Infections

Explore clinical trials studying Respiratory Tract Infections. Study availability and eligibility vary by location and protocol.

9,607 public trials 648 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Tract Infections trial results

Completed

Impact of Information Prescriptions on Medication Adherence in Emergency Department (ED) Patients

NCT01174706

Conditions: Abdominal Pain, Behavior, Body Temperature Changes, +22 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States

Howard County General Hospital Columbia, Maryland, United States

View Trial Details

Completed

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

NCT01059617

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Milford, Massachusetts, United States

GSK Investigational Site Salisbury, North Carolina, United States

GSK Investigational Site Winston-Salem, North Carolina, United States

View Trial Details

Completed

A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine.

NCT00812981

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Taipei, Taiwan

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly

NCT00938392

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Tallinn, Estonia

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Bratislava, Slovakia

GSK Investigational Site Bratislava, Slovakia

View Trial Details

Completed

Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

NCT00968890

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Eskilstuna, Sweden

GSK Investigational Site Örebro, Sweden

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

NCT00742885

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

NCT00706563

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

GSK Investigational Site Dresden, Saxony, Germany

View Trial Details

Completed

Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults

NCT00510874

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Stockbridge, Georgia, United States

View Trial Details

Completed

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

NCT00971425

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Rednitzhembach, Bavaria, Germany

GSK Investigational Site Mainz, Rhineland-Palatinate, Germany

GSK Investigational Site Freital, Saxony, Germany

GSK Investigational Site Berlin, Germany

View Trial Details

Completed

Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control

NCT00778895

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Calgary, Alberta, Canada

GSK Investigational Site Langley, British Columbia, Canada

GSK Investigational Site Winnipeg, Manitoba, Canada

GSK Investigational Site Mount Pearl, Newfoundland and Labrador, Canada

View all 18 locations

View Trial Details